Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M131Revenue $M0.1Net Margin (%)0Z-Score7.5
Enterprise Value $M97.0EPS $-0.1Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %-2.4Quick Ratio13.6Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-11.6Current Ratio13.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-54.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-73.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M179ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with RNN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RNNKen Fisher 2014-09-30 Sold Out $0.662 - $0.875
($0.75)
$ 0.73-3%Sold Out0
RNNKen Fisher 2014-06-30 Buy $0.79 - $1.28
($0.95)
$ 0.73-30%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RNN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


RNN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ahn Chang HoDirector 2015-01-12Sell314,656$0.91-19.78 view
Jeong Tae HeumCFO 2015-01-12Sell317,272$0.91-19.78 view
Ahn Chang HoDirector 2014-06-12Sell136,193$0.99-26.26 view
Jeong Tae HeumCFO 2013-09-09Sell71,139$0.4658.7 view
Kivel RichardDirector 2011-10-03Buy2,500$1.04-29.81 view
Brandt Peter C.Director 2011-09-09Buy125,000$1.17-37.61 view
Brandt Peter C.Director 2011-09-07Buy25,000$0.96-23.96 view
Ahn Chang HoChairman & CEO, 10% Owner 2011-05-18Buy1,008,078$1.31-44.27 view
Ahn Chang HoChairman & CEO, 10% Owner 2011-04-01Buy320,846$1.22-40.16 view
McIntosh David MDirector 2009-07-30Buy5,600$0.8-8.75 view

Press Releases about RNN :

    Quarterly/Annual Reports about RNN:

    News about RNN:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: RNN, IIG, FSC, GEO, DAN May 21 2011 
    Weekly CEO Buys Highlight: GBDC, EXL, RNN, KYN, CMTL Apr 09 2011 

    More From Other Websites
    New Data Show Rexahn's Supinoxin(TM) Decreases the Migration of Human Triple Negative Breast Cancer... Apr 21 2015
    New Data Show Rexahn's Supinoxin(TM) Decreases the Migration of Human Triple Negative Breast Cancer... Apr 21 2015
    Rexahn Identifies RX-3117 Biomarker & Presents Data at the 2015 American Association for Cancer... Apr 20 2015
    Rexahn Identifies RX-3117 Biomarker & Presents Data at the 2015 American Association for Cancer... Apr 20 2015
    Rexahn Pharmaceuticals to Present Data on RX-3117 and Supinoxin(TM) at the 2015 American Association... Apr 13 2015
    Print Apr 13 2015
    Rexahn Pharmaceuticals to Present Data on RX-3117 and Supinoxin(TM) at the 2015 American Association... Apr 13 2015
    REXAHN PHARMACEUTICALS, INC. Financials Mar 21 2015
    UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic... Mar 20 2015
    Coverage initiated on Rexahn Pharmaceuticals by MLV & Co Mar 20 2015
    Rexahn Pharmaceuticals to Present at the 12th Annual BIO Asia International Conference in Tokyo,... Mar 18 2015
    Rexahn Pharmaceuticals to Present at the 12th Annual BIO Asia International Conference in Tokyo,... Mar 18 2015
    Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Pipeline... Mar 17 2015
    Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Pipeline... Mar 17 2015
    REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 16 2015
    Rexahn Pharmaceuticals to Present at the BIO-Europe Spring(R) 2015 Conference in Paris, France Mar 04 2015
    Rexahn Pharmaceuticals to Present at the BIO-Europe Spring(R) 2015 Conference in Paris, France Mar 04 2015
    Rexahn Pharmaceuticals to Present at the ROTH Capital Partners 27th Annual Growth Stock Conference Mar 02 2015
    Rexahn Pharmaceuticals to Present at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum... Feb 18 2015
    Rexahn Pharmaceuticals to Present at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum... Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK